World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
60
Citations
12759
World Ranking
3331
National Ranking
1545

Research.com Recognitions

  • 2006 - Distinguished Service Award, Clinical Immunology Society

Overview

Mark Ballow is affiliated with the University of South Florida in the United States and has an extensive record of research publications primarily in the fields of Medicine and Immunology and Microbiology. Their work focuses on immunodeficiency, autoimmune disorders, and related hematological and infectious disease topics.

The recent publications coauthored by Ballow include:

  • Secondary Immune Deficiency and Primary Immune Deficiency Crossovers: Hematological Malignancies and Autoimmune Diseases (2022) in Frontiers in Immunology
  • Why Do Some People Develop Serious COVID-19 Disease After Infection, While Others Only Exhibit Mild Symptoms? (2021) in The Journal of Allergy and Clinical Immunology In Practice

Ballow frequently collaborates with other researchers, including Jolán E. Walter, Elena Pérez, Heather K. Lehman, Charlotte Cunningham-Rundles, and Jennifer W. Leiding.

The primary publication venues where Ballow has contributed papers are:

  • The Journal of Allergy and Clinical Immunology In Practice
  • Frontiers in Immunology
  • Immunology and Allergy Clinics of North America
  • Journal of Allergy and Clinical Immunology
  • Clinical Reviews in Allergy & Immunology

Ballow's research spans several subfields, including:

  • Immunology
  • Genetics
  • Infectious Diseases
  • Hematology
  • Epidemiology

The main topics addressed in their work cover:

  • Immunodeficiency and Autoimmune Disorders
  • Chronic Lymphocytic Leukemia Research
  • Platelet Disorders and Treatments
  • Parvovirus B19 Infection Studies
  • Blood disorders and treatments
  • Respiratory viral infections research
  • COVID-19 Clinical Research Studies

Among awards received, Ballow was honored with the Distinguished Service Award by the Clinical Immunology Society in 2006.

Best Publications

  • Newborn Screening for Severe Combined Immunodeficiency in 11 Screening Programs in the United States

    Antonia Kwan;Roshini S. Abraham;Robert Currier;Amy Brower

  • Update on the use of immunoglobulin in human disease: A review of evidence

    Elena E. Perez;Jordan S. Orange;Francisco Bonilla;Javier Chinen

  • Use of intravenous immunoglobulin in human disease: A review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology

    Jordan S. Orange;Elham M. Hossny;Catherine R. Weiler;Mark Ballow

  • A randomized double-blind trial

    Chaim M. Roifman;Harry Schroeder;Melvin Berger;Ricardo Sorensen

  • Use and interpretation of diagnostic vaccination in primary immunodeficiency: A working group report of the Basic and Clinical Immunology Interest Section of the American Academy of Allergy, Asthma & Immunology

    Jordan S. Orange;Mark Ballow;E. Richard Stiehm;Zuhair K. Ballas

  • Two Anticomplementary Factors in Cobra Venom: Hemolysis of Guinea Pig Erythrocytes by One of Them

    Mark Ballow;Charles G. Cochrane

  • Primary immunodeficiency disorders: Antibody deficiency

    Mark Ballow

  • Development of The Immune System in Very Low Birth Weight (Less than 1500 g) Premature Infants: Concentrations of Plasma Immunoglobulins and Patterns of Infections

    M Ballow;K L Cates;J C Rowe;C Goetz

  • The IgG molecule as a biological immune response modifier: Mechanisms of action of intravenous immune serum globulin in autoimmune and inflammatory disorders

    Mark Ballow

  • Mechanisms of action of intravenous immune serum globulin in autoimmune and inflammatory diseases

    Mark Ballow

  • Chronic Mononucleosis Syndrome

    Richard DuBOIS;Janet Seeley;Irena Brus;Kiyoshi Sakamoto

  • A superantigen hypothesis for the pathogenesis of chronic hyperplastic sinusitis with massive nasal polyposis.

    Joel M Bernstein;Mark Ballow;Patrick M Schlievert;Gary Rich

  • Comparison of the efficacy of IGIV-C, 10% (caprylate/chromatography) and IGIV-SD, 10% as replacement therapy in primary immune deficiency ☆: A randomized double-blind trial

    Chaim M Roifman;Harry Schroeder;Melvin Berger;Ricardo Sorensen

  • Recommendations for live viral and bacterial vaccines in immunodeficient patients and their close contacts

    William T. Shearer;Thomas A. Fleisher;Rebecca H. Buckley;Zuhair Ballas

  • Use of intravenous immunoglobulin and adjunctive therapies in the treatment of primary immunodeficiencies: A working group report of and study by the Primary Immunodeficiency Committee of the American Academy of Allergy Asthma and Immunology.

    Pierre L. Yong;John Boyle;Mark Ballow;Marcia Boyle

  • Modulation of suppressor-cell activity by cimetidine in patients with common variable hypogammaglobulinemia.

    William B. White;Mark Ballow

  • Complete absence of the third component of complement in man.

    M Ballow;J E Shira;L Harden;S Y Yang

  • Retinoic Acid Enhances the Production of IL-10 While Reducing the Synthesis of IL-12 and TNF-α from LPS-Stimulated Monocytes/Macrophages

    Xiaochuan Wang;Cheryl Allen;Mark Ballow

  • Biosynthesis of the third component of complement (C3) in vitro by monocytes from both normal and homozygous C3-deficient humans.

    L P Einstein;P J Hansen;M Ballow;A E Davis rd

  • Cyclosporine treatment of autoimmune chronic active hepatitis.

    Jeffrey S. Hyams;Jeffrey S. Hyams;Mark Ballow;Mark Ballow;Alan M. Leichtner;Alan M. Leichtner

  • Newborn Screening for SCID in New York State: Experience from the First Two Years

    Beth H. Vogel;Vincent Bonagura;Geoffrey A. Weinberg;Mark Ballow

Frequent Co-Authors

Robert A. Good
Robert A. Good University of Minnesota
Charlotte Cunningham-Rundles
Charlotte Cunningham-Rundles Icahn School of Medicine at Mount Sinai
Francisco A. Bonilla
Francisco A. Bonilla Boston Children's Hospital
Melvin Berger
Melvin Berger CSL (Switzerland)
Jordan S. Orange
Jordan S. Orange University of Pennsylvania
Rebecca H. Buckley
Rebecca H. Buckley Duke University
Erwin W. Gelfand
Erwin W. Gelfand University of Colorado Anschutz Medical Campus
Noorbibi K. Day
Noorbibi K. Day University of South Florida
Hans D. Ochs
Hans D. Ochs University of Washington
Zuhair K. Ballas
Zuhair K. Ballas University of Iowa

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Immunology, exploring related online degrees can expand career opportunities, especially within healthcare fields. One promising path is becoming a Psychiatric-Mental Health Nurse Practitioner (PMHNP). Several pmhnp programs online with best clinical placement offer solid clinical experiences that improve job prospects after graduation.

Cost is another important consideration. Prospective students can find quality education without breaking the bank by researching the cheapest online pmhnp programs. These programs provide accessible pathways to enter psychiatric nursing roles while maintaining affordability.

After earning a Doctor of Nursing Practice (DNP) degree, graduates often want to know their earning potential. The doctor of nursing practice salary varies by location, with many states offering competitive compensation aligned with the position’s clinical demands and specialties.

Nurses aiming to shift focus can explore specialized fields such as acute care. Dedicated acute care nurse practitioner programs provide the education needed to manage complex patient cases, bridging family nursing with intensive care expertise.

Best Scientists Citing Mark Ballow

Trending Scientists

Recently Published Articles